Oxygen Therapy Market

The global oxygen therapy market size is expected to reach USD 18.2 billion in 2024.

Over 4.2 million beds for patients in hospitals, long-term care, nursing homes, and home care need to be equipped with oxygen in the United States.

AN URGENT NEED

According to a 2018 report published by Grand View Research, the increasing patient population is expected to boost the demand for oxygen therapy products. This surge is attributable to the demand for portable technology by consumers, and the clinical urgency for greater support for the geriatric population.

 

Patient Experience:

Lack of oxygenation can manifest as respiratory distress, cyanosis, rapid onset of fatigue, and problems with memory and concentration.

 

The Impact of Oxygen Therapy:

Oxygen therapy is also a prominent therapeutic treatment for patients
suffering from Interstitial Lung Disease, COVID, Pulmonary Arterial  Hypertension, COPD, and many other life-threatening conditions.

 

Patient Priorities:

Patients want to retain their mobility while undergoing oxygen therapy. Remote monitoring is of high value to the quality of life.

In a recent survey conducted by Jacobs et. Al, oxygen therapy patients report:

65%

DO NOT HAVE THEIR OXYGEN SATURATION CHECKED REGULARLY

AIRS-WebIcons-32 Calendar.png
AIRS-WebIcons-48 Monitor.png
67%

ARE UNABLE TO REGULARLY TITRATE THEIR O2

51%

REPORT ONE OR MORE OXYGEN EQUIPMENT ISSUES

AIRS-WebIcons-12 Oxygen Tanks.png

The AIRS Oxygen Monitoring Solution

Advanced Interactive Response Systems (AIRS) was founded to bring needed oxygen monitoring, regulation, data, and reporting solutions to the market. The Grand View Research report cites technologically advanced oxygen sources and delivery devices that feature efficient, convenient patient care will be a major boost to the industry.

AIRS produces high-quality safety and monitoring products that improve patient health and caregiver performance.
medical-doctor-looking-at-his-smartphone-device-2021-08-30-08-18-45-utc_edited.jpg

Since its founding in 2014 and very first patent, AIRS has made great strides in improving 02 therapy better for caregivers and patients. Our mission is to be the leader in technology and quality of care solutions for COPD and O2 therapy patients by partnering with quality organizations and dedicating ourselves to improving the lives of oxygen-dependent patients, the institutions, and caregivers who rely on O2 therapy.

Advanced-Interactive-Response-Systems-AIRS-About.png